Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • Newsroom
  • Publications & data
  • Tools
  • About us

Search

Filter by:
Page 1 of 4 // 39 Results found

Event

Flu Awareness Campaign 2021

Campaign

The Flu Awareness Campaign is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.

  • Immunisation
  • Influenza in humans, seasonal
  • Vaccination coverage
  • Vaccine effectiveness
  • Vaccine efficacy
  • Vaccine hesitancy

Event

Flu Awareness Week, 5-9 October 2020

Campaign
5 Oct 2020 - 9 Oct 2020
World Health Organization (WHO) - Regional office for Europe

The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.

  • Immunisation
  • Influenza in humans, seasonal
  • Vaccination coverage
  • Vaccine effectiveness
  • Vaccine efficacy
  • Vaccine hesitancy

News

Looking at newer enhanced seasonal influenza vaccines: a systematic review of efficacy, effectiveness and safety

News story - 5 Oct 2020

Based on a systematic literature review, ECDC assessed the efficacy, effectiveness and safety of newer and enhanced inactivated seasonal influenza (flu) vaccines among those 18 years or older. These assessed are MF59® adjuvanted, cell-based, high-dose, and recombinant haemagglutinin influenza vaccines.

  • Immunisation
  • Influenza in humans, seasonal
  • Vaccine efficacy
  • Vaccine preventable diseases

Publication

Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines

Technical report - 1 Oct 2020

Overall the evidence base for the efficacy and effectiveness of newer and enhanced influenza vaccines appears limited at present, with a number of potentially relevant studies identified as ongoing.

Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals aged 18 years and over - EN - [PDF-10.35 MB]
  • Immunisation
  • Influenza
  • Influenza in humans, seasonal
  • Prevention and control
  • Vaccine efficacy

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)

Peer-Reviewed Publication

Dec 2019 - Vaccine X - 3

Kissling, E., Pozo, F., Buda, S., Vilcu, A.-M., Rizzo, C., Gherasim, A., Horváth, J.K., Brytting, M., Domegan, L., Meijer, A., Paradowska-Stankiewicz, I., Machado, A., Vučina, V.V., Lazar, M., Johansen, K., Dürrwald, R., van der Werf, S., Bella, A., Larrauri, A., Ferenczi, A., Zakikhany, K., O'Donnell, J., Dijkstra, F., Bogusz, J., Guiomar, R., Filipović, S.K., Pitigoi, D., Penttinen, P., Valenciano, M.

  • Epidemiology
  • Europe
  • Immunisation
  • Influenza
  • Influenza in humans, seasonal
  • Reference laboratory
  • Vaccine effectiveness
  • Vaccine efficacy

Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort

Peer-Reviewed Publication

Nov 2019 - Euro Surveill. - 24(48)

Kissling, E., Pozo, F., Buda, S., Vilcu, A.-M., Gherasim, A., Brytting, M., Domegan, L., Gómez, V., Meijer, A., Lazar, M., Vučina, V.V., Dürrwald, R., van der Werf, S., Larrauri, A., Enkirch, T., O'Donnell, J., Guiomar, R., Hooiveld, M., Petrović, G., Stoian, E., Penttinen, P., Valenciano, M., I-Move Primary Care Study Team

  • Canada
  • Epidemiology
  • EU/EEA
  • Europe
  • Immunisation
  • Influenza
  • Influenza A (H1N1)
  • Reference laboratory
  • United States
  • Vaccine effectiveness
  • Vaccine efficacy

Event

Flu Awareness Week, 21-25 October 2019

Campaign
21 Oct 2019 - 25 Oct 2019
World Health Organization (WHO) - Regional office for Europe

The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.

  • Immunisation
  • Influenza
  • Influenza in humans, seasonal
  • Vaccine effectiveness
  • Vaccine efficacy
  • Vaccine hesitancy

Event

Flu Awareness Week, 22 – 26 October 2018

Campaign
22 Oct 2018 - 26 Oct 2018
World Health Organization (WHO) - Regional office for Europe

The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.

  • EU/EEA
  • Europe
  • Immunisation
  • Influenza
  • Influenza in humans, seasonal
  • Vaccine effectiveness
  • Vaccine efficacy
  • Vaccine hesitancy

News

Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic

Press release - 7 Feb 2018

Influenza vaccination coverage among high-risk groups has dropped in the European Region over the last seven years, and half the countries report a decrease in the number of vaccine doses available.

  • Europe
  • Immunisation
  • Influenza
  • Influenza in humans, pandemic
  • Influenza in humans, seasonal
  • Vaccination coverage
  • Vaccine effectiveness
  • Vaccine efficacy
  • Vaccine hesitancy

Publication

Expert opinion on rotavirus vaccination in infancy

Expert opinion - 7 Sep 2017

ECDC has published an Expert Opinion on rotavirus vaccination in infancy. The paper provides EU/EEA Member States with relevant scientific information on burden of rotavirus disease, vaccine effectiveness and safety, and cost-effectiveness studies to support the decision-making process on the possible introduction of routine vaccination of children against rotavirus gastroenteritis.

Expert opinion on rotavirus vaccination in infancy - EN - [PDF-2.08 MB]
  • Burden of communicable diseases
  • EU/EEA
  • Immunisation
  • Rotavirus infection
  • Scientific advice
  • Vaccine effectiveness
  • Vaccine efficacy
  • Vaccine preventable diseases
  • Vaccine safety

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy
  • Personal data protection
  • Language policy
  • Cookies
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2022
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Search:
  • Home
  • All topics: A to Z
  • Newsroom
  • Publications & data
  • Tools
  • About us